Hydrofarm Holdings Group Q2 2025 Earnings Report

Hydrofarm Holdings Group EPS Results

• Actual EPS: -$3.63
• Consensus EPS: -$2.39
• Beat/Miss: Missed by -$1.24
• One Year Ago EPS: N/A

Hydrofarm Holdings Group Revenue Results

• Actual Revenue: $39.25 million
• Expected Revenue: $51.00 million
• Beat/Miss: Missed by -$11.76 million
• YoY Revenue Growth: N/A

Hydrofarm Holdings Group Announcement Details

• Quarter: Q2 2025
• Date: 8/12/2025
• Time: Before Market Opens
• Conference Call Date: Tuesday, August 12, 2025
• Conference Call Time: 8:30AM ET

Hydrofarm Holdings Group (NASDAQ:HYFM), together with its subsidiaries, manufactures and distributes controlled environment agriculture (CEA) equipment and supplies in the United States and Canada. The company provides agricultural lighting devices, indoor climate control equipment, and nutrients, as well as plant additives used to grow, farm, and cultivate cannabis, flowers, fruits, plants, vegetables, grains, and herbs in controlled environment. It is also involved in the distribution of CEA equipment and supplies comprising nutrients and fertilizers; grow light systems; horticulture benches and racking systems; heating, ventilation, and air conditioning systems; humidity and carbon dioxide monitors and controllers; water pumps, heaters, chillers, and filters; and various growing media typically made from soil, peat, rock wool or coconut fiber, and others. The company offers its products to specialty hydroponic retailers, commercial resellers and greenhouse builders, garden centers, hardware stores, and e-commerce retailers under the Active Air, Active Aqua, Aurora Peat Products, HEAVY 16, House & Garden, Gaia Green, Grotek, Innovative Growers Equipment, Mad Farmer, Phantom, PHOTOBIO, Procision, Roots Organics, Soul, and SunBlaster brands. It serves its products through a range of commercial and home gardening equipment and supplies retailers. Hydrofarm Holdings Group, Inc. was founded in 1977 and is based in Shoemakersville, Pennsylvania.

Hydrofarm Holdings Group Q2 2025 Earnings Call Transcript

Key Takeaways

• Positive Sentiment: During Q2, HydroPharm delivered its twelfth consecutive quarter of year-over-year adjusted SG&A savings, cutting expenses by nearly 16% and generating positive free cash flow.
• Positive Sentiment: The company launched its 2025 restructuring plan, rationalizing over one-third of SKUs and brands to optimize its portfolio and expects annual cost savings in excess of $3,000,000, with roughly one-third of benefits in 2025.
• Negative Sentiment: Net sales fell by 28.4% year over year in Q2, driven by industry oversupply and weak durable lighting and equipment demand, leading to a drop in both gross profit and adjusted gross profit margins.
• Positive Sentiment: Consumable products outperformed durables, increasing to approximately 80% of quarterly sales, with strong year-over-year performance from proprietary brands in nutrients and grow media categories.
• Positive Sentiment: Non-cannabis and international sales grew, improving diversification outside the U.S. and Canada and laying the groundwork to enhance high-quality revenue streams across Europe and Asia.

Presentation

[Operator]

Day, ladies and gentlemen, and thank you for standing by. Welcome to the HydroPharm Holdings Group Second Quarter twenty twenty five Earnings Conference Call. At this time, all participants have been placed in a listen only mode, and the lines will be open for your questions following the presentation. Please note that this conference is being recorded today, 08/12/2025. I would now like to turn the call over to John DiTomenico at ICR to begin.

[Jonathan DeDomenico, VP - IR at ICR]

Thank you, and good morning. With me on the call today is John Lindeman, HydroPharm's Chief Executive Officer and Kevin O'Brien, the company's Chief Financial Officer. By now, everyone should have access to our second quarter twenty twenty five earnings release and Form eight ks issued this morning, as well as an investor presentation available for reference. These documents are available on the Investors section of HydroPharm's website at www.hydropharm.com. Before we begin our formal remarks, please note that our discussion today will include forward looking statements.

[Jonathan DeDomenico, VP - IR at ICR]

These forward looking statements are not guarantees of future performance, and therefore, you should not put undue reliance on them. These statements are also subject to numerous risks and uncertainties that could cause actual results to differ materially from our current expectations. We refer all of you to our recent SEC filings for a more detailed discussion of the risks that could impact our future operating results and financial condition. Lastly, during today's call, we will discuss non GAAP measures, which we believe can be useful in evaluating our performance. The presentation of this additional information should not be considered in isolation or as a substitute for results prepared in accordance with GAAP, and reconciliations to comparable GAAP measures are available in our earnings release.

[Jonathan DeDomenico, VP - IR at ICR]

With that, I would like to turn the call over to John Lindeman.

[B. John Lindeman, CEO & Director at Hydrofarm]

John, and good morning, everyone. During the second quarter, we delivered our twelfth consecutive quarter of year over year adjusted SG and A savings with a nearly 16% reduction in expenses compared to 2024. These substantial savings helped drive a small sequential improvement in adjusted EBITDA compared to the first quarter of this year despite the tariff environment. Our disciplined approach to working capital management and inventory optimization also allowed us to deliver positive free cash flow for the quarter. We also took a significant step in the quarter with the initiation of a new restructuring plan to enhance our focus on higher margin brands and to further optimize our distribution and manufacturing network.

[B. John Lindeman, CEO & Director at Hydrofarm]

We expect this initiative over the next several quarters to drive higher quality revenue streams and improve our level of profitability. Second quarter sales and sales mix came in softer than anticipated as industry headwinds continue to impact our top line performance, in particular on the durable side of our business. There continues to be oversupply challenges in the market, consolidation across the retail customer base and minimal real progress made by the government on rescheduling and safer banking. These dynamics have led to inconsistent demand, most notably on the Lighting and Durable side of our business, which is heavily weighted towards proprietary brands. With that said, there are several positives to call out from our performance within the quarter.

[B. John Lindeman, CEO & Director at Hydrofarm]

To start, we saw solid year on year performances on a relative basis from several of our proprietary consumable brands in the nutrients and grow media categories. And while the lighting and durable side of the business overall was very soft in Q2, we did see strong performance from our Sun Blaster brand behind early results from our innovative and award winning Nano and Halo plant lights. As part of this initiative to drive high quality sales, we also have additional new branded products launching later this year. During the quarter, we also experienced positive performance in some of our newer distributed brands. Our team is excited to work with our distributed brand partners who are committed to aligning closely with us and investing behind their brands to support growth and deliver strong margin and cash flow characteristics.

[B. John Lindeman, CEO & Director at Hydrofarm]

However, we are becoming increasingly selective and in our restructuring program announced today, we took the step to rationalize several distributor brands that do not fit those characteristics. We saw further progress in our non cannabis and non US Canadian sales mix during the quarter. Our international sales in particular performed well, improving year on year with nice results in select European and Asian countries. We remain on pace to improve upon the full year metric we achieved last year and continue to seek ways to diversify our revenue streams. Under our fully integrated ERP system, we have begun to realize improved working capital management, which helped to deliver positive free cash flow.

[B. John Lindeman, CEO & Director at Hydrofarm]

Managing our free cash flow and our overall financial position remains a key area of focus for us, and we remain on pace to deliver positive free cash flow for the last nine months of 2025. We have made it clear that our top strategic priority is to drive diverse, high quality revenue streams. After positive momentum in the first quarter of this year, which saw our proprietary brand sales mix improve to 55%, our mix softened in the second quarter due in large part to poor industry demand levels in the durables category. Behind our restructuring initiatives and select planned investments in the second half, we still expect to improve our proprietary mix and adjusted gross profit margin for the full year. Last quarter, we indicated that we would conduct a thorough review of our product portfolio and distribution network to better align with estimated sales demand in the current industry and tariff environment.

[B. John Lindeman, CEO & Director at Hydrofarm]

In Q2, we completed that process and as a result, initiated our new 2025 restructuring plan. This plan further streamlines our product portfolio and our manufacturing and distribution footprint. These actions include a large reduction in the number of SKUs and distributed brands that we will carry going forward. By trimming these underperforming products, we reduce our purchasing and warehousing complexity, reduce our space and personnel requirements, limit our working capital investment and enable our sales team to focus their efforts on higher value brands. We estimate these actions collectively will result in annual cost savings in excess of $3,000,000 plus incremental improvements in working capital.

[B. John Lindeman, CEO & Director at Hydrofarm]

And importantly, we expect approximately one third of the total benefit to start showing through in the 2025. Our strong history of impactful restructuring and cost saving measures gives us confidence that we will over time realize these benefits. In the 2025, we also plan to invest more in marketing behind new innovations, improve our brand websites and further refine our internal CRM capabilities. All of these actions are oriented to drive higher quality revenue streams. I would like to give an update on the ongoing uncertain tariff environment.

[B. John Lindeman, CEO & Director at Hydrofarm]

As a reminder, our primary tariff exposure is in our durables business as we source certain lighting and equipment products from China. We typically maintain larger inventory positions and products sourced from overseas, and as such, we have not yet realized a dramatic impact from tariffs outside of approximately $300,000 of incremental costs year to date. We are managing our business to minimize the impacts from tariffs and are carefully purchasing from vendors abroad in situations where the incremental tariff costs can either be shared with our suppliers or passed on to customers in a limited manner. In addition, we have and will continue to enact pricing actions when necessary and where possible in an effort to preserve our margins. With all of that said, it's important to note that the largest part of our business is our consumables portfolio, and this business is mainly sourced from within The U.

[B. John Lindeman, CEO & Director at Hydrofarm]

S. And Canada, albeit there is a portion sourced from other countries. We are increasingly focused on our proprietary consumables business, and with tariffs primarily affecting durables, it is logical for us to maintain that focus. We are executing what is within our control. We believe that by concentrating our efforts on a more optimized product portfolio and manufacturing and distribution footprint, we are positioned much better to drive diverse, high quality revenue streams, improve profit margins and strengthen our financial position.

[B. John Lindeman, CEO & Director at Hydrofarm]

With that, I'll hand it over to Kevin to further discuss the details of our second quarter financial results and our new 2025 restructuring plan.

[Kevin O’Brien, CFO at Hydrofarm]

Thanks, John, and good morning, everyone. Net sales for the second quarter were $39,200,000 down 28.4 year over year, driven primarily by a 27.9% decline in volume mix and a 0.4% decline in pricing. The declines were primarily related to industry oversupply. While we were successful at driving improvements in our higher margin proprietary brands during the first quarter, continued industry headwinds and lower performance in our durable lighting and equipment products led to a decline in Q2. We are focused on improving our proprietary brand mix in the 2025 and are planning increased investments behind our key brands along with executing our restructuring plan as John discussed earlier.

[Kevin O’Brien, CFO at Hydrofarm]

Consumable products outperformed durable products on a relative basis And as a result, our consumables mix ticked up to approximately 80% of sales in the second quarter. Gross profit in the second quarter was $2,800,000 or 7.1 percent of net sales compared to $10,900,000 or 19.8% of net sales in the year ago period. Second quarter twenty twenty five gross profit was negatively impacted by $3,300,000 of restructuring charges we incurred during the quarter related to non cash inventory write downs. Adjusted gross profit was $7,500,000 or 19.2% of net sales compared to $13,300,000 or 24.4% of net sales last year. The decrease was due to lower net sales and a decline in proprietary brand sales mix.

[Kevin O’Brien, CFO at Hydrofarm]

As John said, we continue to expect improvement in adjusted gross profit margins for the full year 2025 as we improve our mix and reduce costs. I'll now provide further detail on our new restructuring plan and cost saving initiatives. In response to the prolonged industry headwinds as well as the evolving tariff situation, During the second quarter, we initiated a restructuring plan to narrow and optimize the size and scope of our product portfolio and related footprint. The restructuring plan entails rationalizing over one third of SKUs and brands in our product portfolio across The U. S.

[Kevin O’Brien, CFO at Hydrofarm]

And in Canada, where our portfolio is much larger given the nature of our garden center business. The restructuring is intended to simplify our offering and optimize how we manage our inventory as one operating segment. In connection with the product portfolio optimization, we are reducing our footprint, including in our distribution center and manufacturing facilities. We estimate annual cost savings in excess of $3,000,000 and working capital benefits from the restructuring, primarily from a reduction in inventory. We also believe this restructuring will improve efficiency, heighten our focus on our key proprietary brands and help deliver improved profitability.

[Kevin O’Brien, CFO at Hydrofarm]

Moving on to our selling, general and administrative expense. In the second quarter, our SG and A expense was $16,100,000 compared to $18,700,000 last year. Adjusted SG and A expenses were 9,800,000.0 a 16% reduction when compared to $11,600,000 last year. This was our twelfth consecutive quarter of meaningful year over year adjusted SG and A savings. We are now operating well below our pre IPO quarterly adjusted SG and A levels from 2020, a testament to the effectiveness of our cost savings initiatives.

[Kevin O’Brien, CFO at Hydrofarm]

Adjusted EBITDA was a loss of $2,300,000 in the second quarter. The decline from the prior year was due to lower net sales and adjusted gross profit margin, partially offset by adjusted SG and A savings. While the year over year comparison was unfavorable, we did improve sequentially compared to the first quarter while also covering incremental tariff costs. Moving on to the balance sheet and overall liquidity position. Our cash balance as of 06/30/2025 was $11,000,000 During the quarter, we made a $4,500,000 prepayment on our term loan and ended the second quarter with $114,500,000 of principal balance on the term loan and approximately $122,600,000 of total debt inclusive of financial lease liabilities.

[Kevin O’Brien, CFO at Hydrofarm]

Our net debt at the end of the second quarter was approximately $111,600,000 As a reminder, our term loan facility has no financial maintenance covenant and does not mature until October 2028. We also continue to maintain a zero balance on our revolving credit facility. As a reminder, in May, we entered into a seventh amendment to our revolving credit facility, which extended the maturity date to 06/30/2027 and reduced the maximum commitment amount to $22,000,000 With cash on hand and approximately $9,000,000 of availability on our revolving line of credit, we had $20,000,000 of total liquidity as of 06/30/2025. In the second quarter, cash from operating activities was $1,700,000 and capital expenditures were $300,000 yielding free cash flow of 1,400,000.0 Working capital benefits helped to deliver sequential improvements in free cash flow. We believe that we will deliver positive free cash flow for the last nine months of 2025.

[Kevin O’Brien, CFO at Hydrofarm]

To close, during the 2025, we took significant steps to better position our business for improved performance as we move forward. We are committed to executing our strategic priorities and remain optimistic for an eventual demand turnaround in the industry. Thank you for joining us today and we look forward to providing another update in November on our third quarter call. We are now happy to answer your questions. Operator, please open the line.

[Operator]

Thank We'll take our first question from Dmitry Silversteyn with Water Tower Research. Please go ahead. Your line is open.

[Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC]

Good morning, guys. Thank you for taking my question. I want to revisit the tariff impact you mentioned. We've gotten a little bit more of a clarity here as we ended the second quarter with respect of EU and UK, some of the Asian countries where you're trying to grow China excuse me, tariff deadline has been extended here by another three months while negotiations are going on. So can you talk a little bit more about sort of what you expect what you're seeing currently in terms of tariffs and what you expect to see should these negotiations with China not deliver the results that people expect?

[B. John Lindeman, CEO & Director at Hydrofarm]

Yeah, good morning, Demetri and thanks for the question. Yeah, I mean, look, tariffs are certainly hard to track with the news coming out daily, but given how the size, scope and speed of tariff changes have been occurring, it's certainly hard to predict the exact impact on gross margin going forward. I would say thus far in the 2025, I think we've been reasonably successful in covering the incremental cost of tariffs that were incurred on products that mostly for us were sourced out of China during that time period. Going forward in the second half, we'll continue to manage what's within our control with respect to tariffs. You know, we're doing this by sort of very carefully purchasing from vendors abroad in situations where the incremental tariff costs can be shared or passed on to our customers in a limited manner.

[B. John Lindeman, CEO & Director at Hydrofarm]

You know, we're also continuing to review alternative sourcing arrangements from abroad and domestically. And we're also focusing our business on proprietary manufactured brands, which are at least on the manufactured side, for us predominantly consumable products that we make here in The U. S. And Canada. These have the smallest exposure to tariffs and related to durable products, which are more heavily impacted by industry conditions right now.

[B. John Lindeman, CEO & Director at Hydrofarm]

So hopefully, gives you some broad perspective on sort of how we're thinking about going into the second half.

[Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC]

Yes, does, John. Thank you. You kind of segued into my next question, and that's your product portfolio optimization and changes. You talk about growing your proprietary business and and kind of weeding out the the third party nonpropriety, I guess, which you distribute for for other people. What I will ask there is the reason you are distributing third party products through your channels, is it just to expand your portfolio offering or is it sort of offering a generic lower cost alternative to your proprietary products?

[Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC]

In other words, as you continue to weed out third party distribution or distributing third party products, what impact will it have on your portfolio overall and your ability to be a kind of a one stop shop for your customers?

[B. John Lindeman, CEO & Director at Hydrofarm]

Yeah, look, I appreciate the question for sure. Look, we historically and continue to have had many great long term relationships with distributed brand partners. Many of these partners have really helped us form a diverse and broad portfolio of products, which we offer. And this is not going to change for us. Our team continues to be excited to establish new partnerships where there's an innovative product with growth potential and the brand partner is willing to offer sort of fair margin and cash flow characteristics.

[B. John Lindeman, CEO & Director at Hydrofarm]

But as we've talked about, the industry remains challenging, and it makes sense for us to reduce the offering where there are significant redundancies, which are underscore that and or sort of underperforming products. And we took those steps to make changes in their portfolio. We just reported, We did this just to kind of rehash a little bit. So there's clarity on this. You know, we rationalized over a third of the SKUs and brands in our product portfolio across both The US and in Canada.

[B. John Lindeman, CEO & Director at Hydrofarm]

And although, you know, the rationalization of these SKUs and brands were across all the product and brand categories, and wanna be clear, it was across all product and brand categories, the largest proportion of underperforming SKUs and brands that we rationalize were found in the durable products and distributed brand areas. And because in general, these are underperforming products that have not been selling well and carrying below average margins, the impact to our net sales is much less than the onethree call out. And from a gross profit margin perspective, we actually expect to see our adjusted gross profit margin improve over time. So again, we expect to continue to have a broad offering across all the product categories as we do today. But frankly, during the go go times of the industry, I think our portfolio probably came a little bit bloated and we need to continue to trim in spots that it makes sense.

[Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC]

Makes sense, John. Thank you for that granularity. Just switching gears here a little bit, talk about the non cannabis part of your business. From what I understand that your Lone and Garden focus, your focus on e commerce and distribution through that channel is aiding you a little bit here to sort of navigate the difficult times in the cannabis industry. Is there any sort of incremental effort that you're putting behind growing that part of your business?

[Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC]

And is there anything that we should look forward to in the balance of 2025 on that front?

[B. John Lindeman, CEO & Director at Hydrofarm]

Yes, sure. As we sort of talked about in the scripted remarks, our international sales had performed well, certainly on a relative basis, and they actually grew in the quarter on a year over year perspective and with nice results in select European and Asian countries. We continue to press in that area with our team, And we remain on pace to improve upon sort of the full year diversification metric that we've typically reported, which is this non cannabis and non US Canadian sales metric. And how are we doing that? We're doing that with the international piece, which I just mentioned.

[B. John Lindeman, CEO & Director at Hydrofarm]

We're doing that with food and floral sales in The US and Canada. We're doing that with Garden Center in The US and Canada. And we're doing that with e commerce. We've had some success from modifying some of our products to better appeal the non cannabis markets. We've done that in the chiller space.

[B. John Lindeman, CEO & Director at Hydrofarm]

We've done that with some of our rotainers. We've done that with our Sun Blaster lighting products. And we're continuing to look at some areas in the nutrient category along those lines. So lots of things that we're doing to focus our diversification efforts.

[Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC]

Understood. Understood. And then final question. You know, President Trump was recently speaking publicly talking about the fact that he is considering reclassifying cannabis. What have you heard from DC and what are the chances that that's actually going to happen as opposed to be talked about again?

[B. John Lindeman, CEO & Director at Hydrofarm]

Yeah, I just simply say, maybe unlike some others, I'm not sure I have a direct line to Trump, but certainly we've seen the news, the news yesterday, some of the news we saw even the week before the Wall Street Journal and Fox Business. And it certainly sounds like, you know, he's privately or his administration perhaps, I should say, is privately considering rescheduling cannabis. Yeah. Look, we're certainly encouraged by these reports and hope the Trump administration sees it through in a positive with a positive outcome. But, you know, we'll wait in for judgment until until we actually see something.

[B. John Lindeman, CEO & Director at Hydrofarm]

You know, there's been a lot of stops and starts in the past in this area, but certainly the latest development seems really encouraging. And we do think that this would be a positive for the overall industry as it frees up capital and cash flow for a lot of our end users of our products. So we're certainly excited to see a positive outcome here.

[Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC]

Very good, John. Thank you. That's all the questions I have for right now.

[B. John Lindeman, CEO & Director at Hydrofarm]

Thanks, Dimitri.

[Operator]

Thank you. And this does conclude our Q and A session as well as the conference call. Thank you all for your participation, and you may disconnect at any time.

Participants

Analysts

• Jonathan DeDomenico, VP - IR at ICR
• B. John Lindeman, CEO & Director at Hydrofarm
• Kevin O’Brien, CFO at Hydrofarm
• Dmitry Silversteyn, Senior Research Analyst at Water Tower Research LLC